Role of Hsp70 in regulation of stress-kinase JNK: implications in apoptosis and aging  by Gabai, Vladimir L et al.
Minireview
Role of Hsp70 in regulation of stress-kinase JNK:
implications in apoptosis and aging
Vladimir L. Gabai, Anatoli B. Meriin, Julia A. Yaglom, Vladimir Z. Volloch,
Michael Y. Sherman*
Boston Biomedical Research Institute, Boston, MA, USA
Received 1 September 1998
Abstract Cell protection from stresses by the major heat shock
protein Hsp72 was previously attributed to its ability to prevent
aggregation and to accelerate refolding of damaged proteins.
This repair function of Hsp72 may play an important role in cell
survival after extremely harsh protein damaging treatments
leading to necrotic cell death. On the other hand, protein repair
function of Hsp72 cannot explain how it protects cells from
stresses which do not cause direct protein damage, e.g. some
genotoxic agents. These stresses kill cells through activation of
apoptosis, and Hsp72 increases cell survival by interfering with
the apoptotic program. Recently it has been found that Hsp72
mediates suppression of a stress-activated protein kinase, JNK,
an early component of stress-induced apoptotic signalling
pathway. This finding provides the basis for the anti-apoptotic
activity of Hsp72. These observations can explain increased
stress sensitivity of aged cells in which compromised inducibility
of Hsp72 leads to a loss of control of JNK activation by stresses
and subsequently to a higher rate of apoptotic death.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Heat shock proteins of Hsp70 family function as molecular
chaperones in protein folding, transport and degradation (see
[1] for review). Members of this protein family, including
Hsp72, are induced in response to stresses and serve to protect
cells against heat shock and other harmful conditions which
cause massive protein damage and denaturation [2,3]. Since
Hsp72 promotes protein folding, this heat shock protein was
suggested to prevent and/or repair stress-induced protein
damages. Indeed, there are many experimental data in the
literature which support this suggestion. For example, over-
expression of Hsp72 strongly decreased heat-induced aggrega-
tion of nuclear proteins as well as inactivation of a reporter
enzyme, ¢re£y luciferase [4^6]. Furthermore, accumulation of
Hsp72 and other heat shock proteins due to the priming of
cells with mild heat shock dramatically reduced aggregation of
actin and other cytoskeletal constituents caused by severe heat
shock [7,8]. Reduction of protein aggregation in cells express-
ing Hsp72 also correlated with an increased survival following
treatment with protein damaging agents such as SH-reagents
(arsenite-diamide) and ethanol [9]. It also correlated with the
increased survival of cells following ischemia or oxidative
stress (see [10] for review). These data taken together have
led to a common and natural assumption that activities of
Hsp72 in refolding, prevention of aggregation and of degra-
dation of damaged polypeptides form the basis of its protec-
tive function.
On the other hand, another set of data in the literature
suggests that Hsp72 plays a distinct role in cell protection.
Several groups reported that Hsp72 prevents cell death after
stresses that do not cause detectable protein damage. For
example, overproduction of Hsp72 protected cells from death
caused by UV irradiation [11], etoposide [12], doxorubicin
[13], and from a death induced by signalling molecules,
TNF [14] and NO [15] (Table 1). Furthermore, it was found
that overproduction of Hsp72, while protecting cells from a
DNA-damaging anticancer drug doxorubicin, did not reduce
DNA lesions [13]. Therefore, a new distinct function of Hsp72
might exist that plays a major role in cell survival after stress-
es. To better understand the protective action of Hsp72, one
should take a closer look at the mechanisms of cell killing by
stresses.
2. Apoptosis as a novel mode of stress-induced cell death
Originally investigators distinguished two modes of cell
death under hyperthermia and other stresses: (i) necrosis,
which is associated with marked damage of intracellular struc-
tures and cytoplasmic membrane, followed by the leakage of
the cellular constituents; and (ii) reproductive death, which is
manifested by the loss of the colony-formation ability. After
extreme stresses (e.g. heating at more than 46^47‡C) mamma-
lian cells usually die via necrosis, while milder stresses do not
cause visual damage but nevertheless lead to the loss of re-
productive ability. In addition, recently it became clear that
cells die via the third mode of death ^ apoptosis after non-
extreme heat shock (44^45‡C), UV or ionizing irradiation,
oxidative stress, exposure to heavy metals, and other stresses
[16^18]. Apoptotic program activates membrane blebbing, mi-
tochondrial damage, degradation of some proteins and nu-
clear DNA and other events, which ultimately culminate in
cell death (see [19^21] for review). Recent data indicate that
under pathological conditions such as heart or brain ischemia,
Alzheimer’s, Huntington’s and other neurodegerative diseases,
apoptosis is the major contributor to cell death [20,22].
In contrast to necrosis, in the apoptotic process initial
stress-induced damage does not kill cells directly. Rather, it
triggers an apoptotic signalling program that leads to the cell’s
suicide. It is of importance that suppression of this signalling
pathway can completely prevent the loss of cell viability. The
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apoptotic program involves several major players, including
mitochondrial membrane proteins of the bcl-2 family, a family
of cysteine proteinases (caspases), and stress-activated
kinases; inactivation of these components by a number of
methods dramatically raises survival of cells exposed to stress-
es [17,19^21]. For example, overproduction of anti-apoptotic
proteins bcl-2 and bcl-x prevents cell death under many stress-
ful conditions [21]. Similarly, speci¢c inhibition of caspases,
which are involved in execution of apoptosis, markedly im-
proves cell survival after the stresses [19]. Likewise, inhibition
of a stress-activated protein kinase JNK, another component
of the apoptotic signalling pathway, prevents apoptosis in-
duced by a variety of stresses, including heat shock, ethanol,
UV irradiation, oxidative stress and others [23^27] (Table 1).
This was demonstrated by interruption of the JNK signalling
pathway either immediately upstream of JNK (by expression
of dominant-negative mutants of the JNK activator SEK1)
[23,26] or immediately downstream of JNK (by expression
of a dominant negative mutant of JNK substrate, c-jun)
[26,28].
3. Hsp72 regulates activity of stress kinase KNL
How does Hsp72 protect cells from stresses and other stim-
uli that do not cause direct protein damage (‘non-proteotoxic’
stresses) like UV irradiation, TNF, NO, etoposide and others
(Table 1)? It is likely that Hsp72 can somehow interfere with
the apoptotic program initiated by these stimuli, thus allowing
cells to survive. Similarly, interference with the apoptotic pro-
gram rather than repair of damaged proteins may explain the
protective e¡ect of Hsp72 against mild proteotoxic stresses,
like heat shock, ethanol, amino acid analogs, etc.
The hypothesis that Hsp72, when present at an elevated
level, inhibits apoptosis has been recently tested by several
groups. It was clearly demonstrated that elevated levels of
Hsp72 strongly reduced activation of caspases, and sup-
pressed other manifestations of apoptosis such as membrane
blebbing, mitochondrial damage, and nuclear fragmentation
[29^32]. Using the lymphoid cell line PEER stably transfected
with a plasmid which encodes Hsp72 under the regulation of
an inducible promoter, our group and, independently, Mosser
et al. [30] have found that Hsp72 a¡ects the apoptotic path-
way at a very early stage, namely it prevents activation of a
stress kinase, JNK. In fact, activation of JNK in response to
heat shock, ethanol and certain other stresses was dramati-
cally reduced in cells with transiently increased levels of this
heat shock protein [30,31]. Similar results were obtained with
other cell lines including primary cultures of human ¢bro-
blasts, embryonic cardiomyocytes, and other cells which ex-
pressed Hsp72 transiently from an adenovirus-based vector
([33] and unpublished data). It is noteworthy that the same
blockade of JNK activation was achieved when Hsp72 was
induced by physiological conditions (mild heat shock) or by a
drug, proteasome inhibitor MG132 [28,31]. Furthermore,
there is a clear correlation between the dependence of apop-
tosis on activation of JNK and suppression of apoptosis by
elevated expression of Hsp72. Indeed, as shown in Table 1,
apoptosis after all the stresses which activate cell death via the
JNK signalling pathway, could be suppressed by Hsp72. In
contrast, JNK-independent apoptosis initiated by FAS, TCR
or TNF (in certain cell lines) cannot be suppressed by Hsp72.
These data indicate that JNK or regulators of JNK activity is
the site(s) of inhibitory action of Hsp72 on the apoptotic
program.
Although Hsp72 can suppress apoptosis induced by the
stresses which do not cause detectable protein damage, there
is still a remote possibility that such stresses cause a minor
undetectable protein damage which is su⁄cient to activate
JNK and subsequently apoptosis. At this scenario, Hsp72
repairs such damage, thus protecting cells, and hence the func-
tion of Hsp72 in suppression of JNK could be explained
purely by Hsp72’s chaperone activity. We think this possibil-
ity is unlikely, because the function of Hsp72 in suppression
of JNK activation could be separated from its function in
protein refolding. Indeed, we have observed that a mutant
Hsp72 lacking the ATPase domain and therefore unable to
promote refolding is still capable of suppressing JNK activa-
tion and heat-induced apoptosis (manuscript in preparation).
Similarly, Dr. D. Mosser observed that a mutant Hsp72 lack-
ing four C-terminal amino acids suppresses JNK activation
(Mosser, personal communication), but is unable to bind
damaged proteins and even inhibits protein refolding by nor-
mal Hsp72 [34]. Therefore, suppression of JNK does not re-
quire chaperone function, and Hsp72 plays a distinct role in
JNK signalling.
The suppression of JNK by Hsp72 sheds new light on the
phenomenon of acquired stress tolerance, i.e. that mild heat
shock followed by the recovery period makes cells resistant to
hyperthermia, doxorubicin, ethanol and other stresses [13,18].
Mild heat shock initiates two processes: it rapidly and tran-
siently activates JNK to a relatively low level which is insu⁄-
cient to turn on the apoptotic process, and induces slow (with-
in several hours) accumulation of Hsp72 [31]. After a recovery
period, the accumulated Hsp72 suppresses the activation of
JNK following exposure of cells to stresses and cells do not
undergo apoptosis.
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Table 1
Hsp72-mediated projection and JNK dependence of apoptotic cell death
Stimuli Hsp72-mediated protection JNK dependence of apoptosis References
Heat shock + + [26,30,31]
Ethanol + + [28,31]
UV + + [11,26,37]
Oxidative stress + + [11,15,26]
Etoposide + + [12,25]
Proteasome inhibitors + + [28]
TNF +/3a +/3a [14,26]
TCR/CD3 activation 3 3 [51,52]
Fas 3 3 [51,52]
aAbsence of protection by Hsp72 and JNK-independent apoptosis was demonstrated in some cell lines [28,53].
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Potentially, there could be other mechanisms of interference
of Hsp72 with the apoptotic pathway, independent of sup-
pression of JNK. This possibility was seemingly supported
by the fact that in contrast to inducible expression of recombi-
nant Hsp72, constitutive expression of this protein did not
suppress JNK activation immediately following heat shock,
although it protected cells from apoptosis and inhibited acti-
vation of caspases [30,32]. It was suggested therefore that
Hsp72 has an additional target in the apoptotic program
downstream of JNK and upstream of caspases. Although
this is a plausible hypothesis, this experimental system is
somewhat problematic. Hsp72 expressed at high levels consti-
tutively is toxic for a cell [35], which could lead to selection of
a variety of unpredictable adaptive changes in surviving cells.
It is conceivable that during establishing cell lines that chroni-
cally overproduce Hsp72, resistant mutant variants with de-
fects in the apoptotic machinery downstream of JNK were
selected. In addition, using Rat-1 cells stably expressing hu-
man Hsp72 at high levels [29,36], we have found that although
the initial levels of JNK activation following heat shock are
not a¡ected, JNK activity decays in these cells much faster
than in control cells (manuscript in preparation). Prolonged
JNK activation was shown by several groups to be critical for
apoptosis (e.g. [37,38]) and therefore e¡ects of Hsp72 on
apoptosis could potentially be explained solely by its e¡ects
on JNK. Moreover, e¡ects of the regulated acute overexpres-
sion of Hsp72 on JNK are identical to that of elevated levels
of Hsp72 induced by mild heat shock (i.e. classical heat shock
response), indicating that the JNK pathway is the physiolog-
ically relevant target of Hsp72 in protection of cells from
apoptosis [28,31,32].
Another important implication of the new ¢nding of
Hsp72-mediated suppression of the JNK signalling pathway
is in cell apoptosis following heart ischemia and stroke. In-
deed, overproduction of Hsp72 was shown to strongly protect
heart and brain cells from the ischemia/reperfusion injuries
both in vitro and in animal models (see [10] for review). These
¢ndings stimulated a search for non-toxic Hsp72 inducers to
be used for treatment of ischemia and related conditions. As
mentioned above, the protective action of Hsp72 in ischemia-
induced necrosis was previously explained by the Hsp72-medi-
ated prevention of protein aggregation [7,39]. However, in the
cells undergoing apoptosis after ischemia/reperfusion suppres-
sion of JNK is likely to play a major role in Hps72-mediated
protection. First, ischemia/reperfusion strongly activates JNK
and a homologous kinase p38 in cardiomyocytes [40,41], and
their simultaneous activation is su⁄cient to cause apoptosis in
these cells [42], and second, in H9c2 myogenic cells subjected
to simulated ischemia/reperfusion, both JNK and p38 activ-
ities were inhibited after expression of Hsp72 which correlated
with increased survival (Gabai et al., manuscript in prepara-
tion). Therefore protective action of Hsp72 could be associ-
ated with inhibition of JNK and p38 after ischemia/reperfu-
sion.
4. Hsp72 and aging
The discovered phenomenon of suppression of the JNK
signalling pathway by Hsp72 has an important implication
in aging. Aged organisms exhibit a greatly decreased ability
to induce Hsp72 and other heat shock proteins in response to
stresses [43], which correlates with the increase in morbidity
and mortality of aged organisms exposed to hyperthermia
[43,44]. Diminishing of inducibility of Hsps and increasing
of sensitivity to stresses with aging could also be observed
in cell cultures. Indeed, cells isolated from aged organisms,
as well as cells isolated from young organisms and aged in
culture, show reduced ability to induce Hsps and reduced rate
of survival upon exposure to stresses [43]. We suggested that,
owing to the diminished inducibility of Hsp72 in aged cells,
Hsp72-mediated control of JNK in response to stresses is
compromised, thus resulting in a higher rate of apoptosis.
In fact, aged human primary ¢broblasts IMR90 which passed
62^67 population doublings could not induce Hsp72 after
pretreatment with mild heat shock, and subjecting of such
cells to severe heat shock led to strong activation of JNK
and massive apoptosis [33]. By contrast, young cells which
passed only 12^17 population doublings accumulated Hsp72
after mild heat shock pretreatment. This led to suppression of
JNK and greatly reduced apoptosis following a severe heat
shock [33]. It is important that the loss of control of JNK in
aged cells can be attributed exclusively to the diminished
Hsp72 inducibility. Indeed, forced expression of recombinant
Hsp72 from an adenovirus-based vector suppressed activation
of JNK by heat shock and consequently protected from heat-
induced apoptosis [33].
We suggest that the compromised induction of heat shock
proteins in aged cells could be a special adaptive cellular re-
sponse rather than just a non-speci¢c damage of transcription
system. In other words, it is possible that induction of Hsps in
aged cells is speci¢cally inhibited in order to preserve ability
to activate JNK and probably other homologous stress
kinases in response to stimuli. It has been shown that the
primary signal for induction of Hsps after heat shock and
other stresses in accumulation of damaged proteins; under
these conditions a transcription factor HSF1 is activated
and initiates transcription of Hsp72 and other Hsp genes
[45,46]. It is important to note that cells aged in culture or
isolated from aged organism have an increased level of abnor-
mal proteins. Indeed, it has been reported that such cells have
high levels of oxidatively damaged polypeptides (see [47,48]
for review). Furthermore, both normal aged cells and cells
a¡ected by age-related diseases (e.g. Alzheimer’s, Hunting-
ton’s, and others) have increased amounts of polyubiquitin-
ated proteins [49], suggesting that although the ubiquitinating
machinery is functional, 26S proteasome in aged cells for
some reason cannot degrade certain ubiquitinated polypep-
tides. Therefore, if HSF1 were functional in aged cells, con-
stantly present abnormal polypeptides would ultimately acti-
vate it, and heat shock proteins including Hsp72 would be
permanently expressed at high levels. Such elevated expression
of Hsp72 would lead to suppression of the JNK signalling
pathway and apoptosis in response to stresses. Consequently,
aged cells would become resistant to many apoptotic inducers.
This, in turn, may potentially have disastrous consequences
for the whole organism, for instance, increased incidence of
oncogenic transformation. Aged cells, therefore, may over-
come this problem by repressing HSF1, and thus reducing
the ability to induce Hsps. It should be noted that prolonged
presence of abnormal proteins in a cell (not necessarily an
aged cell) was suggested by Welch and Gambetti to trigger
the repression of Hsps inducibility [50].
In summary, the new ¢nding of suppression of stress kinase
JNK by Hsp72 not only delineates the protective function of
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this heat shock protein but also explains increased sensitivity
to stresses in aged cells, and has signi¢cant implications in
treatment of ischemia, and probably other pathological con-
ditions.
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